Smart drug strikes a hidden RNA weak point in cancer cells
Researchers have designed a new class of drug molecule capable of specifically destroying TERRA, an RNA molecule that some cancer cells rely on to survive. Using a technique known as…
24TimeNews Cover a wide range of topics from politics and business to entertainment and sports and news stories.
Researchers have designed a new class of drug molecule capable of specifically destroying TERRA, an RNA molecule that some cancer cells rely on to survive. Using a technique known as…
A new targeted drug delivery system called TAR-200 has shown remarkable results in a phase 2 clinical trial, eliminating tumors in 82% of patients with high-risk non-muscle-invasive bladder cancer that…
An international team of researchers has identified a new weakness in prostate cancer cells that could lead to more effective treatments for one of the most common cancers among men.…
Just as the universe began with a colossal explosion, bowel cancer also experiences a “Big Bang” moment that determines how it will grow and spread, according to new research supported…
In a major step toward improving cancer treatment, researchers at Northwestern University have redesigned the molecular structure of a widely used chemotherapy drug, making it far more soluble, potent, and…
Throughout life, our cells are continually exposed to both internal and external influences that can harm DNA. This DNA damage is a well-known factor in the development of aging and…
Scientists have developed a promising cancer therapy that uses LED light and ultra-thin flakes of tin to eliminate cancer cells while protecting healthy tissue. Unlike traditional chemotherapy and other invasive…
People with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of beginning immunotherapy lived considerably longer than those who did not, according to new…
Men whose prostate cancer returns after surgery or radiation therapy may soon benefit from a powerful new treatment that has been shown in clinical trials to reduce the risk of…
Scientists at the Francis Crick Institute and Vividion Therapeutics have discovered chemical compounds that can precisely prevent the cancer-driving gene RAS from connecting with a key pathway responsible for tumor…